London – Great Britain is the first country in the west to a apply in both the US and Europe for approval for emergency use.Vaccine for public use. The British Department of Health and Social Welfare confirmed in a statement to British news agencies that the vaccine developed jointly by the American drug manufacturer Pfizer and the German BioNTech will be marketed from next week. Pfizer was the first of three large Western pharmaceutical companies
“The government today accepted the recommendation from the Independent Medicines and Health Products Regulatory Agency (MHRA) to approve Pfizer / BioNTech’s Covid-19 vaccine for use,” a Department of Health and Social Affairs spokesman told the Press Association of Britain. The spokesman said the emergency clearance was “based on months of rigorous clinical trials and a thorough analysis of the data by experts from the MHRA, who concluded that the vaccine met its stringent standards of safety, quality and effectiveness.”
In accordance withUK frontline health workers, nursing home residents, the very elderly and people with underlying medical conditions that make them particularly vulnerable to COVID-19 complications are expected to receive their first doses of the vaccine. Pfizer’s vaccine, like the Oxford and Moderna formulas, requires two doses about a month apart.
UK Health Secretary Matt Hancock called it “fantastic news” that UK regulators had found the first vaccine safe and vowed that distribution would begin Monday. He told the BBC Breakfast Show that vaccinations would “start” with the oldest people and with people in nursing homes.
Prime Minister Boris Johnson also welcomed the news and tweeted to confirm plans to start introducing cans from next week.
“It’s the protection of vaccines that ultimately allows us to regain our lives and get the economy going again,” said Johnson.
Hancock, Britain’s top public health officer, noticedHowever, the Pfizer vaccine, which must be stored at around -94 degrees Fahrenheit, said the UK would receive its first 800,000 doses next week. A total of 40 million doses of the Pfizer vaccine have been ordered in the UK, enough to fully treat 20 million people.
Two other vaccines, one from the USThis also requires sub-zero storage and storage by the UK pharmaceutical company University, have also applied for emergency permits in the US and Europe.
Both Pfizer and Moderna have said that data from large-scale human studies involving tens of thousands of people showed that their vaccines are about 95% effective in preventing COVID-19 infection. AstraZeneca / Oxford found that their vaccine, which works differently, was up to 90% effective on a given dosing schedule. The vaccine developed in Oxford is much cheaper to manufacture and sell as it only needs to be stored at refrigerator temperatures.
“This is the first emergency approval following a global Phase 3 study of a vaccine to fight the pandemic,” Pfizer and BioNTech said in a joint statement on Wednesday, adding that they “have further regulatory decisions around the world Anticipate “days and weeks in the coming year and be ready to dispense vaccine doses after potential regulatory approvals or approvals.” “
Pfizer CEO Albert Bourla described the move in the UK as “a historic moment in the fight against COVID-19”.
None of the human studies of any of the three leading vaccines from the West found significant adverse effects. Some side effects commonly associated with long-term vaccines, including pain around the injection point, fatigue, and headache, were seen in the study data.
In China and Russia, officials have been administering thousands of doses of COVID-19 vaccines developed by government-sponsored research institutes outside of studies for weeks. Unlike Western vaccination programs, neither Russia nor China conducted large-scale international human trials with data made available for independent analysis before they began their untreatable vaccination programs.
Trust and the “infodemia”
Logistical issues aside, epidemiologists and public health officials around the world have warned that another major hurdle to dragging the coronavirus pandemic behind humanity could be distrust of available vaccines.
On Saturday, the World Health Organization warned that an “infodemic” on social media could deliver humanity to the new coronavirus, which has killed more than 1.5 million people worldwide and nearly 271,000 people in the US alone.
“Coronavirus disease is the first pandemic in history that uses technology and social media on a large scale to keep people safe, informed, productive and connected,” a WHO statement said. “At the same time, the technology we rely on to stay connected and stay informed is enabling and reinforcing an infodemic that continues to undermine the global response and undermine action to combat the pandemic.”
The WHO suggested that online platforms as well as politicians and other influential figures “make deliberate attempts to disseminate false information”, which aroused distrust of science and health institutions.
“Without proper trust and information, diagnostic tests will not be used, vaccination campaigns (or campaigns promoting effective vaccines) will not achieve their goals, and the virus will continue to thrive,” warned WHO.
ONEConducted at the beginning of September, there was growing skepticism about the coronavirus vaccines under development. Most voters said if a vaccine were made available this year, their first thought would be that it would be thrown without adequate testing.
Only 21% of voters across the country said in the poll that if it were available for free, they would get a vaccine as soon as possible, down from 32% in a poll conducted in late July. Most said they would think about it, but see what happens to others before you get one yourself.
In this pandemic, pharmaceutical companies and research institutes have worked with governments and independent regulators to cut the normally long process of vaccine development and approval into a much shorter period of time.
The pace was brand new, but the bodies involved, along with outside infectious disease and vaccine experts, insisted that the process be safely compressed, mainly by overlapping steps that are usually sequential rather than eliminating steps in the testing and testing Certification process.
Hancock, the UK government’s health chief, told UK broadcaster Piers Morgan on Wednesday that if they could approve, despite not belonging to a risk group, he would love to be vaccinated live on TV next week to show Morgan Confidence in the vaccine.